Next Generation Technologies for Diabetes Therapy and Drug Delivery

  • ID: 3645919
  • Report
  • Region: Global
  • 95 Pages
  • Frost & Sullivan
1 of 3
Depicting the Perfect Scenario for Cutting-edge Technology Convergence in Biomedical Sciences
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030.

The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are working on both the development of novel drugs to fight diabetes, and on the design of novel insulin delivery systems. These delivery systems mostly via use oral and pulmonary routes using nanocarrier-based delivery systems, as well as transdermal delivery to through patches and infusion pumps, which aim to improve the quality of life of diabetic patients.

An important new business model is emerging between large pharmaceutical/biopharmaceutical companies and medical devices firms with the objective of accelerating the delivery of novel therapeutic systems to the industry. Medical device companies and drug manufacturing companies sign long-term partnership agreements to combine their drug delivery devices with the most-active diabetes therapeutics, thereby bringing down the operational costs and saving a significant amount of time during the process.

This research examines the current landscape and new trends in diabetes drug delivery, focusing on: Technology trends and capability Stakeholder activities, influence, industry initiatives, and applications targeted Industry initiatives, regulation, and standardization approaches for tackling challenges Technology benchmarking for specific applications An appendix is included, comprising lists of the major participants in the study and the most notable patents in the field.
Note: Product cover images may vary from those shown
2 of 3
1. Executive Summary
  • Research Scope
  • Research Methodology
  • Key Findings
2. Industry Models and Market Trends
  • Industry Value Chain and Business Model
  • Diabetes Drug Delivery Market Impact
  • Diabetes Drug Delivery Regional Revenue Growth
  • Diabetes Drug Delivery Business Facts
3. Innovation Potential and Clinical Translation
  • Diabetes Drug Delivery Innovation Fields
  • Diabetes Drug Delivery Innovation in Pharma/Biotech
  • Diabetes Drug Delivery Innovation in Medtech
  • Diabetes Drug Delivery Innovation in Synertech
  • Diabetes Drug Delivery Innovation Model
  • Diabetes Drug Delivery Development Pipeline
4. Key Innovations Profiled
  • Pharma/Biotech - Insulin Human Inhalation Powder
  • Pharma/Biotech - TANZEUM (albiglutide)
  • Pharma/Biotech - XIGDUO XR
  • Pharma/Biotech - Xultophy (IDegLira)
  • Pharma/Biotech - Smart Insulin
  • Pharma/Biotech - Bile Acid Microcapsules
  • Medtech - FreeStyle Libre Flash Glucose Monitoring
  • Medtech - Smart Contact Lenses for Glucose Monitoring
  • Medtech - Microneedle Pill with Hollow Needles
  • Medtech - Autoantibody Measuring Microchip
  • Medtech - SmartGuard GlucoSitter
  • Medtech - iLet Bihormonal Bionic Pancreas
  • Medtech - ITCA 650
  • Medtech - G-Pen Mini™ Glucagon Injection
  • Synertech - Glucose Nanosensors
  • Synertech - Cell Reprogramming via Nanotechnology
  • Synertech - 3D Bioplotted Hydrogel Scaffolds
  • Synertech - Spherical Nucleic Acids
  • Synertech - Engineering ß-Cell Replacement Therapy
  • Synertech - Glucose-Responsive Insulin-Producing Cells
  • Other Innovative Technologies to Watch
  • Diabetes eHealth Applications to Follow
5. Technology Benchmarking
  • Multi-criteria Approach for Benchmarking
  • R&D Benchmarking - Framework
  • R&D Benchmarking - Main Strengths by Company
  • Final Remarks
6. Intellectual Property Trends
  • Intellectual Property
7. Appendix
  • Key Industry Contacts
  • Key Academic Contacts
  • Intellectual Property Sources
  • Key Granted Patents
  • Legal Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll